Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (71-80 of 302) with videos related to

Pageof 31
Sort By:
Expert Review of Anticancer Therapy|October 18, 2008
Role of thalidomide in previously untreated patients with multiple myelomaPellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
European Journal of Haematology|June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" QuestionsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
American Journal of Hematology|January 26, 2017
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPIJulio Delgado, Michael Doubek, Tycho Baumann, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Journal of Translational Medicine|December 2, 2021
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumabRosaria De Filippi, Fortunato Morabito, Armando Santoro, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Leukemia & Lymphoma|June 14, 2011
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphomaLuigi Marcheselli, Raffaella Marcheselli, Alessia Bari, et al.
Leukemia Research|November 4, 2011
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)Stefano Molica, Giovanna Digiesi, Anna Antenucci, et al.
Cancer|December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemiaStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
European Journal of Haematology|May 25, 2010
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugsFortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
Pageof 31

Showing results (71-80 of 302) with videos related to

Sort By:
Pageof 31
Expert Review of Anticancer Therapy|October 18, 2008
Role of thalidomide in previously untreated patients with multiple myelomaPellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
European Journal of Haematology|June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" QuestionsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
American Journal of Hematology|January 26, 2017
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPIJulio Delgado, Michael Doubek, Tycho Baumann, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Journal of Translational Medicine|December 2, 2021
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumabRosaria De Filippi, Fortunato Morabito, Armando Santoro, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Leukemia & Lymphoma|June 14, 2011
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphomaLuigi Marcheselli, Raffaella Marcheselli, Alessia Bari, et al.
Leukemia Research|November 4, 2011
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)Stefano Molica, Giovanna Digiesi, Anna Antenucci, et al.
Cancer|December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemiaStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
European Journal of Haematology|May 25, 2010
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugsFortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
Pageof 31